Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

BACKGROUND: The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MU...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chin Med J (Engl)
Autors principals: Ge, Jun-Bo, Fan, Wei-Hu, Zhou, Jing-Min, Shi, Hai-Ming, Ji, Fu-Sui, Wu, Yang, Zhao, Yu-Lan, Qian, Jun, Jin, Yuan-Zhe, Liu, Ying-Wu, Wang, Sheng-Huang, He, Sheng-Hu, Yang, Ping, Wu, Jie, Lu, Feng, Hou, Zi-Shan
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817287/
https://ncbi.nlm.nih.gov/pubmed/33273369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001257
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars